Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001194 · ClinicalTrials.gov registry record
NMR Scanning on Patients
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 99,999
- Enrollment target
NCT00001194: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT00001194 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 99,999 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001194 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 99,999 participants
- Enrollment target
Study Summary
This protocol is designed to investigate the use of novel techniques in MRI that may not yet be commercially available. Specifically, the protocol enables patients to take advantage of new pulse sequence software, coil design or post processing capabilities not otherwise available. The informed consent explains MRI in lay terms, describes the use of contrast agents and lists contraindications to MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99,999 participants |
| Start Date | 1984-04 |
| Est. Completion | 2001-02 |
What the finished NCT00001194 record still lists
NCT00001194 is an observational study that tracks outcomes without assigning an intervention. Its 99,999 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001194 about?
NCT00001194 is a clinical study titled "NMR Scanning on Patients". This protocol is designed to investigate the use of novel techniques in MRI that may not yet be commercially available. Specifically, the protocol enables patients to take advantage of new pulse sequence software, coil design or post processing capabilities not otherwise available. The informed cons...
What is the current status of trial NCT00001194?
This trial is currently completed. The enrollment target is 99,999 participants. The study started on 1984-04. Estimated completion is 2001-02.
Who is sponsoring clinical trial NCT00001194?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01351545 · 99,999 participants
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia